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The effects of Newcastle disease virus (NDV) fusion (F) glycoprotein cleavage mutants on the cleavage and
syncytium-forming activity of the wild-type F protein were examined. F protein cleavage mutants were made by
altering amino acids in the furin recognition region (amino acids 112 to 116) in the F protein of a virulent
strain of NDV. Four mutants were made: Q114P replaced the glutamine residue with proline; K115G replaced
lysine with glycine; double mutant K115G, R113G replaced both a lysine and an arginine with glycine residues;
and a triple mutant, R112G, K115G, F117L, replaced three amino acids to mimic the sequence found in
avirulent strains of NDV. All mutants except Q114P were cleavage negative and fusion negative. However,
addition of exogenous trypsin cleaved all mutant F proteins and activated fusion. As expected for an oligomeric
protein, the fusion-negative mutants had a dominant negative phenotype: cotransfection of wild-type and
mutant F protein cDNAs resulted in an inhibition of syncytium formation. The presence of the mutant F
protein did not inhibit cleavage of the wild-type protein. Furthermore, evidence is presented that suggests that
the mutant protein and the wild-type protein formed heterooligomers. By measuring the syncytium-forming
activity of the wild-type protein at various ratios of expression of mutant and wild-type protein, results were
obtained that are most consistent with the notion that the size of the functionally active NDV F protein in these
assays is a single oligomer, likely a trimer. That a larger oligomer, containing a mix of both wild-type and
mutant F proteins, has partial activity cannot, however, be ruled out.
Paramyxoviruses such as Newcastle disease virus (NDV) are
a class of enveloped viruses which fuse with cell plasma mem-
branes at neutral pH (reviewed in reference 7). Because fusion
occurs at neutral pH, cells infected with these viruses can fuse
with adjacent cells, resulting in giant, multinucleated cells, or
syncytia (7). Most paramyxovirus-mediated fusion is directed
by the combined action of the two virus-encoded glycoproteins,
the attachment protein (hemagglutinin-neuraminidase pro-
tein, or HN) and the fusion (F) protein (reviewed in reference
9). Expression of both of these proteins in transfected cells is
necessary and sufficient for syncytium formation. While the
HN protein is required for attachment as well as another
undefined role in fusion, the fusion protein is thought to be
directly involved in fusion and, in one case, can mediate fusion
independent of the HN protein (1).
The NDV F protein is synthesized as a precursor, F0, which,
to be fusogenic, must be cleaved at a site 116 amino acids from
the amino terminus, resulting in disulfide-linked F2 and F1 (21,
22). Cleavage is accomplished by host cell proteases (reviewed
in reference 10). Fusion proteins encoded by the virulent
strains of NDV have amino acid sequences at the cleavage site
which are substrates for the furin family of proteases and are
thus cleaved intracellularly in the trans-Golgi membranes. Fu-
sion proteins encoded by avirulent strains do not have this
sequence motif but rather encode single basic residues and are
cleaved by extracellular enzymes, such as a protease released
by Clara cells in the respiratory tract or a factor X-like activity
in the allantoic fluid of embryonated eggs (reviewed in refer-
ence 10). Cleavage of these fusion proteins in tissue culture
depends upon the addition of exogenous trypsin (16).
Paramyxovirus fusion proteins exist as noncovalently linked
oligomers. It has been reported that both the Sendai virus F
protein (23) and the respiratory syncytial virus F protein are
tetramers (4). However, other reports support the notion that
the oligomer is a trimer composed of three disulfide-linked
F1-F2 molecules (17, 18). All of these studies, however, mea-
sured the physical size of the fusion protein on sucrose gradi-
ents or in polyacrylamide gels. In no case has the functionally
active size of the fusion protein oligomer been investigated. In
several systems, it has been suggested that large complexes of
several glycoprotein oligomers may be required for fusion. For
example, it has been proposed that initial stages in fusion
mediated by the influenza virus hemagglutinin require a com-
plex of at least three trimers on the basis of effects on fusion of
different concentrations of cell surface hemagglutinin protein
(5). Other studies have proposed even larger complexes (2). In
human immunodeficiency virus-infected cells, through com-
parisons of the activity of wild-type protein in the presence of
various amounts of a dominant negative mutant, it has been
suggested that several oligomers of gp41 are required to me-
diate membrane fusion (6).
The effects of NDV fusion-negative mutant proteins on the
wild-type protein activity were characterized. Mutations were
introduced into the cleavage site of the F protein derived from
a virulent strain of NDV in order to generate uncleaved and,
therefore, inactive forms of the F protein. As expected for an
oligomeric protein, the fusion-negative proteins had a domi-
nant negative phenotype. By measuring the syncytium-forming
activity of the wild-type protein at various ratios of expression
of mutant and wild-type protein, results were obtained that are
consistent with the notion that the size of the functionally
active NDV F protein in syncytium formation is an oligomer,
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likely a trimer. A very similar approach for determining the
active unit of the influenza virus M2 protein has been recently
reported (20).
MATERIALS AND METHODS
Cells, vectors, and viruses. Cos-7 cells, obtained from the American Type
Culture Collection, were maintained in Dulbecco’s modified Eagle medium
(DMEM) supplemented with nonessential amino acids, vitamins, penicillin-
streptomycin, sodium bicarbonate, and 10% fetal calf serum.
NDV HN and F genes, characterized previously (25), were expressed in Cos
cells with pSVL obtained from Pharmacia.
Site-specific mutagenesis. Mutagenesis reactions were done with the mutagen-
esis kit from 5 Prime33 Prime, Inc. The appropriate oligomers (22 to 26
nucleotides in length) were used for each mutation. The mutations isolated are
shown in Fig. 1. With one exception, mutants are named, in the single-letter
code, with the amino acid in the wild type and with the position of the change and
the amino acid in the mutant. Thus Q114P is a mutant which has a proline
substituted for a glutamine at amino acid 114 in the F protein sequence. The
triple mutant R113G, K115G,F117L was named AF (for avirulent F) for ease of
presentation. The mutants AF and K115G were modified by insertion of the Flag
sequence (DYKDDDDK) just prior to the chain termination codon at the
carboxy terminus of the protein to produce AF-Flag and K115G-Flag.
Transfections. Transfections with Lipofectin were done essentially as recom-
mended by the manufacturer, BRL GIBCO. Cos cells were plated at 3 3 105 per
35-mm-diameter plate. Twenty to 24 h later, the cells were transfected. For each
35-mm-diameter plate, a mix of DNA (up to 2 mg) in 0.1 ml of OptiMem (BRL
GIBCO) and 10 mg of Lipofectin in 0.1 ml of OptiMem was incubated at room
temperature for 15 min and then diluted with 0.7 ml of OptiMem and added to
a plate previously washed with OptiMem. Cells were incubated with the Lipo-
fectin-DNA for 4 to 5 h, which was then replaced with 2 ml of Cos cell media.
Transfections with Lipofectamine were accomplished as recommended by the
manufacturer essentially as described above. Transfections were also accom-
plished with DOPE (dioleoyl-L-a phosphatidylethanolamine) prepared as de-
scribed by Campbell (3). This reagent was used in protocols identical to that
described above for Lipofectin.
Antibody, radiolabeling, and immunoprecipitation of protein. The antibody
used for immunoprecipitation of the fusion protein was anti-Ftail (27). This
antibody is a polyclonal rabbit antibody raised against a synthetic peptide with
the sequence of the cytoplasmic tail of the fusion protein as described by Wang
et al. (28) and was prepared by the Peptide Core Facility of the University of
Massachusetts Medical School. Anti-Flag antibody (M2) was purchased from
Kodak.
Transfected cells were radiolabeled for 2 to 4 h at 37°C in Dulbecco modified
Eagle medium lacking methionine and cysteine but containing 100 mCi of
[35S]methionine and [35S]cysteine (New England Nuclear Express 35S) per ml
and chased in nonradioactive media for 4 h. Cells were then washed in phos-
phate-buffered saline (PBS) and lysed in RSB buffer (0.01 M Tris-HCl [pH 7.4],
0.01 M NaCl) containing 1% Triton X-100, 0.5% sodium deoxycholate, and 2 mg
of iodoacetamide per ml as previously described (25–27). Nuclei were removed
by centrifugation. Immunoprecipitation of NDV proteins was accomplished as
previously described (11, 12). Precipitated proteins were resolved on 10% poly-
acrylamide gels as previously described (11, 12).
In some experiments, cells were incubated for 10 min at room temperature in
5 mg of acetylated trypsin per ml in OptiMem after plates had been washed with
OptiMem. After trypsin digestion, monolayers were washed in OptiMem con-
taining soybean trypsin inhibitor (7.5 mg/ml).
Fusion assays. Fusion activity was determined by syncytium formation. For
syncytium formation, Cos cells were cotransfected with wild-type or mutant
fusion protein genes and the wild-type HN protein gene with Lipofectin. At 24
and 48 h posttransfection, the number of nuclei in 40 fusion areas were counted
to determine the average size of syncytia at each time point as previously de-
scribed (25). Values obtained after transfection of the vector alone were sub-
tracted.
Chemical cross-linking. Cross-linking with 3,39-dithiobis(sulfosuccinimidyl
proprionate) (DTSSP) (Pierce) was accomplished by a modification of the pro-
tocol described by Russell et al. (18). For cross-linking of cell surface molecules,
radioactivity labeled cells were washed in PBS (pH 8.5) and then incubated with
1 mM DTSSP in PBS at 4°C overnight. The cross-linker was quenched in 50 mM
glycine for 5 min, and the cells were washed with PBS and then lysed at 4°C in
1% Triton X-100. For cross-linking of cell extracts, radioactively labeled cells
were lysed in 1% Triton X-100 and then incubated in 1 mM DTSSP for 2 h at
4°C. After being quenched with glycine, the radioactively labeled, cross-linked
proteins were precipitated as described above.
RESULTS
Expression of mutant proteins. Figure 1 shows the amino
acid sequence of the cleavage site of the AV strain (virulent) of
NDV (wild type). Four new mutants were made in this region
with the goal of eliminating cleavage of the expressed F pro-
tein. First, the glutamine at amino acid 114 was changed to
proline to determine if this residue could eliminate intracellu-
lar cleavage by altering the conformation of the cleavage site.
Two other mutants altered the furin consensus site either by
substituting the lysine at amino acid 115 with glycine or sub-
stituting glycine residues for both lysine 115 and arginine 113.
Glycine was substituted because the avirulent F protein con-
tains glycine at position 115 as well as three glycine residues at
positions 110, 111, and 112 (19). Mutant AF contained the
sequence found at the cleavage site of avirulent strains of NDV
(19). The mutant F117L has been previously described (14)
and was included here for comparative purposes.
The mutant proteins were expressed in Cos-7 cells with
simian virus 40-based vector as previously described (25). Cells
transfected with either wild-type or mutant fusion protein
genes were radioactively labeled with [35S]methionine and
[35S]cysteine in a pulse-chase labeling protocol, and labeled
protein was precipitated with anti-Ftail. In this and other ex-
periments, all mutant proteins were expressed in amounts
equivalent to those of the wild type (Fig. 2). F protein precip-
itated from wild-type transfected cells contained cleaved fusion
protein (F1) as well as small amounts of uncleaved F0 (Fig. 2B,
2trypsin). F2 is not visible on 10% gels (17). Mutant Q114P
protein was also cleaved to the same extent as the wild-type
protein (Fig. 2B). Thus, the nonconservative mutation at this
position had no effect on furin recognition. Since cleavage
likely occurs in the trans-Golgi membranes (15), the cleavage
of this protein also indicates that the mutation has no effect on
intracellular transport. In contrast to the Q114P mutation, all
mutations which altered the furin recognition motif reduced
cleavage of F0 to less than 20% (Fig. 2B, 2trypsin; Table 1).
The F117L protein was also minimally cleaved as previously
reported (14).
All mutants, however, were readily cleaved if trypsin was
added to intact cells prior to cell lysis (Fig. 2B, 1trypsin; Table
1). The amount of cleaved F1 was approximately 70 to 80%,
that of wild-type protein. Because trypsin was added only to
intact cells, these results clearly demonstrated that all mutant
proteins were transported to the cell surface as efficiently as
wild-type proteins. Addition of trypsin to cells expressing the
wild-type protein did not significantly increase the amount of
cleaved F protein, a result that suggests that the F0 detected
was likely due to residual intracellular protein.
FIG. 1. Location of cleavage site mutations. Shown at the top is the sequence
at the cleavage site of the F protein of the virulent NDV strain AV (wild type
[WT]). The arrow indicates the site of cleavage. The amino acid changes (in
boldface) and the name of each mutant are shown below the wild-type sequence.
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Fusion activity of mutant proteins in the absence and pres-
ence of trypsin. To measure the ability of these mutant pro-
teins to direct membrane fusion, Cos cells were transfected
with the mutant fusion protein genes as well as the wild-type
HN gene. The fusion activities of these mutant proteins were
determined as previously described (17, 24, 25, 27) and are
shown as a percentage of the value obtained with wild-type F
protein (Fig. 3). As expected, in the absence of trypsin, Q114P
directed the formation of syncytia at levels comparable to
those of wild-type F protein, while expression of the cleavage-
negative mutants did not result in significant syncytium forma-
tion. However, after addition of trypsin, all mutant proteins
could direct syncytium formation, although to different extents.
The reason that mutants K115G, R113G,K115G, and AF do
not direct as extensive fusion as the wild-type F protein is
unclear, since all mutants are cleaved to the same extent after
trypsin addition.
Addition of trypsin to the wild-type protein-expressing cells
did not increase the fusion activity. This result was consistent
with the results described above, which suggested that the F0
detected in wild-type transfected cells was intracellularly lo-
cated.
Effect of mutant F protein on the cleavage of wild-type pro-
tein. Like other glycoproteins, oligomerization of the F pro-
teins occurs in the rough endoplasmic reticulum (RER) (18)
prior to cleavage of F0 to F11F2, which occurs in the trans-
Golgi membranes (15). However, it is unclear if all subunits in
an oligomer must be cleaved in concert or if individual mem-
bers of the oligomer are cleaved independently. To explore this
question, the extent of cleavage of a constant amount of wild-
type protein in the presence of increasing expression of a
mutant protein was determined (Fig. 4). Clearly, while the
amount of F0 increased with increasing expression of mutant
protein, the amount of F1 detected was unchanged. Thus, the
presence of uncleaved fusion protein had no detectable effect
on the cleavage of the wild-type protein.
Wild-type and mutant proteins form heteroligomers. One
interpretation of the result shown in Fig. 4 is that individual
members of an oligomer are cleaved independent of the cleav-
age of other members of an oligomer. If so, then it should be
FIG. 2. Expression of mutant proteins in the absence and presence of added trypsin. In duplicate, Cos cells, transfected with vector, pSVL (SVL), wild-type F DNA
(WT), or mutant DNAs, were radioactively labeled with [35S]methionine and [35S]cysteine for 2 h at approximately 48 h posttransfection and then subjected to a
nonradioactive chase for 2 h. One set of cells was incubated with trypsin (indicated at the top of the figure), as described in Materials and Methods, prior to lysis.
Proteins present in equivalent amounts of cell extract were precipitated with excess anti-Ftail antibody, and the resulting precipitated proteins were resolved on 10%
polyacrylamide gels in the absence (2b-ME) (A) or presence (1b-ME) (B) of reducing agent b-mercaptoethanol. The mutant DNA used for each transfection is
indicated at the top of the figure. Fnr, nonreduced fusion protein containing both F0 and F11F2; F0, uncleaved fusion protein; F1, the cleaved fusion protein. F2 is not
resolved on this gel. Marker, infected cell extract.
TABLE 1. Cleavage of mutant proteins in the presence and
absence of trypsin
DNA
% Cleavagea
Without trypsin With trypsin
Wild type 0.73 0.79
Q114P 0.73 0.82
K115G 0.16 0.71
F117L 0.36 0.77
R113G,K115G 0.10 0.74
AF 0.06 0.75
a Results are the average of two experiments, both of which yielded very
similar values.
FIG. 3. Fusion activity of mutant proteins without and with trypsin activation.
In duplicate, Cos cells were transfected with equal amounts of HN protein DNA
and either wild-type (WT) F protein or mutant F protein DNAs. At 48 h
posttransfection, one set of monolayers was incubated with trypsin as described
in Materials and Methods. After 10 to 12 h of further incubation, the sizes of
syncytia were measured as previously described (24). The values obtained are
expressed as percentages of that obtained with the wild-type F protein DNA.
Error bars indicate the variation in three independent experiments.
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possible to demonstrate the presence of heterooligomers, or
oligomers that contain both the cleaved and uncleaved forms
of the protein. To explore the formation of heterooligomers,
the Flag epitope was inserted at the carboxy terminus of the F
protein sequence of the mutants AF and K115G. Addition of
this epitope had no effect on the intracellular transport of the
F protein (unpublished observations). Cells were transfected
with either of these mutants as well as with wild-type F protein
cDNA and the Flag-tagged mutant F protein was precipitated
with anti-Flag antibody. If heteroligomers form, then precipi-
tates should contain both the uncleaved F protein as well as the
cleaved F protein derived from the wild-type protein gene.
Indeed, precipitates derived from cells cotransfected with the
wild-type protein as well as either of the mutant proteins con-
tain both cleaved as well as uncleaved F protein (not shown).
However, because of the stringent wash conditions required to
visualize F protein above background material, the amount of
F1 detected in the precipitate was low. Thus, cells were sub-
jected to cross-linking, with the membrane-impermeable cross-
linker DTSSP, to stabilize any complexes (Fig. 5).
Cross-linking was accomplished with intact cells (Fig. 5A) as
well as cell lysates (Fig. 5B). In both cases, precipitation of
protein with the anti-Flag antibody resulted in precipitation of
not only the Flag-tagged F0 protein but also the F1 protein,
which must be derived from the wild-type protein, since little
F1 is detected after transfection of the mutant DNAs alone.
The results were similar whether or not the HN protein was
also expressed. Figure 5C shows precipitation of all F proteins
from the total cell extracts with anti-Ftail antibody and shows
that the wild-type protein was expressed.
Fusion activity is proportional to expression of the wild-type
protein. Because the effect of mutant proteins on the activities
of wild-type proteins often provides insight into the function of
the wild-type protein (8), it was of interest to determine the
effects of cleavage mutant proteins on the fusion activity of
wild-type protein. To explore this question, it was first neces-
sary to determine if syncytium size was proportional to the
amount of expression of fusion-active F protein. To address
this question, cells were transfected with various amounts of
wild-type F protein cDNA, and the amount of F protein ex-
pression at each DNA concentration was determined by im-
munoprecipitation from cell extracts (Fig. 6). Clearly the
amount of fusion protein detected increased linearly with the
amount of DNA used for transfection. Next, the syncytium size
at each DNA concentration was measured, and, as shown in
Fig. 7, the size of syncytia at 48 h posttransfection was directly
proportional to the amount of F protein DNA. Thus, syncy-
tium size can be used to measure the effects of mutants on
wild-type activities.
Effect of mutant proteins on wild-type fusion activity. The
effect of cleavage mutants on the activity of the wild-type
protein was determined by cotransfection of Cos cells with
different ratios of wild-type and mutant DNAs. Mutants
K115G and R113G,K115G were selected, since little cleavage
was observed with these mutants, yet trypsin digestion resulted
in significant fusion, suggesting that the conformation of these
mutants was least affected by mutation. The effect of these
mutants on the fusion activity of wild type assayed by syncytium
size and the results were identical. The results obtained with
K115G are shown in Fig. 8. Fusion activity is expressed as a
percentage of wild-type activity as described in Materials and
Methods. Both mutants significantly inhibited the activity of
the wild-type protein. At equimolar ratios of wild-type and
mutant cDNAs, the fusion activity was approximately 12% that
observed with wild-type F alone (Fig. 8). Thus, the mutant
proteins exert a dominant negative phenotype. The dominant
negative phenotype of the cleavage mutants suggested that the
active form of the F protein is an oligomer and that inclusion
of a mutant protein in an oligomer inhibits its activity. Figure
FIG. 4. Mutant F protein does not affect the cleavage of wild-type protein.
Cos cells were transfected with wild-type F DNA (WT) or wild-type F DNA with
increasing amounts of K115G. Radioactively labelled cell extracts, prepared as
described in the legend to Fig. 2, were incubated with anti-Ftail antibody, and the
resulting precipitated protein was electrophoresed in the presence of reducing
agent. F0, uncleaved F protein; F1, the cleaved fusion protein. F2 is not resolved
on this gel. Marker, infected-cell extract.
FIG. 5. Wild-type and mutant proteins form heterooligomers. Cells transfected with the DNAs indicated at the top of each panel were radioactively labeled with
[35S]methionine and [35S]cysteine as described in the legend to Fig. 2. Intact cells were subjected to cross-linking with DTSSP as previously described (A). Cell lysates
were incubated with cross-linker as described in Materials and Methods (B and C). Proteins present in extracts were precipitated with anti-Flag (A and B) or anti-Ftail
(C), and the resulting precipitated proteins were electrophoresed in the presence of reducing agent. Marker, infected-cell extract. The DNAs used are indicated at the
top of each lane. F0, uncleaved F protein; F1, cleaved F protein.
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8 also shows predicted inhibition curves calculated for dimers,
trimers, tetramers, hexomers, and nine-mers (see Discussion).
DISCUSSION
The results presented in this paper characterize the effect of
coexpression of two forms of the NDV F protein, the protein
with a furin sequence, termed wild-type here, and a mutant
protein without such a site. Clearly the synthesis and stability
of the wild-type protein as well as those of the mutant protein
were unaffected. Since the proteins form oligomers in the RER
(18) and cleavage occurs in the trans-Golgi membranes (15), it
seemed possible that a wild-type protein that oligomerized
with a mutant protein in the RER might not be a substrate for
the furin protease if the protease recognized only an oligo-
meric substrate. However, the presence of the mutant protein
had no effect on the cleavage of the wild-type protein. This
result could indicate that cleavage of a wild-type polypeptide
occurs regardless of the sequence at the cleavage site of other
members of the oligomer. Alternatively, it was possible that the
sequence in the cleavage site somehow dictated oligomeriza-
tion specificity. This possibility was not likely, however, since
cross-linking experiments suggested complexes can form be-
tween mutant F0 and the wild-type F1.
The presence of the mutant F protein did, however, inhibit
the fusion activity as measured by syncytium formation. A
dominant negative phenotype of a mutant protein can be in-
terpreted to indicate that a protein functions as an oligomerFIG. 6. F protein expression as a function of amount of transfected DNA.
Cos cells were transfected with vector (SVL) or increasing amounts of wild-type
F DNA (WT). Vector DNA (pSVL) was added to each transfection such that the
total DNA was at 1 mg. The ratios of wild-type and pSVL DNAs are shown at the
top of panel A. The amounts of F protein cDNA used in each transfection are
shown on the x axis in panel B. Transfected cells were radioactively labeled with
[35S]methionine and [35S]cysteine for 4 h at approximately 48 h posttransfection
and then subjected to a nonradioactive chase for 4 h. Cell extracts were precip-
itated with anti-Ftail antibody, and the resulting precipitated proteins were
resolved on 10% polyacrylamide gels in the presence of reducing agent (b-
mercaptoethanol [A]). (B) Quantitation by a densitometer of the total F protein
present in each lane.
FIG. 7. Fusion activity is proportional to the level of F protein expression.
The sizes of syncytia in Cos cells, transfected as described in the legend to Fig.
4, were determined at 48 h posttransfection as described in Materials and Meth-
ods and are shown versus the amount of DNA used in the transfection. Error
bars indicate the actual variation in three independent experiments.
FIG. 8. Predicted and measured fusion activities of wild-type F protein in the
presence of various amounts of mutant proteins. To determine the fusion activity
of wild-type protein in the presence of different amounts of mutant protein, cells
were cotransfected with 1.5 mg of HN protein DNA, and different ratios of
wild-type and K115G DNA were expressed as the fraction that is wild-type DNA.
The syncytium sizes were determined at 48 h posttransfection and are shown as
data points with error bars (experimental curve). Error bars show the actual
variation in three experiments. For each ratio of wild-type and mutant DNAs, the
predicted amount of fusion was determined by calculating the probability of a
fully wild-type oligomer (see text). The different curves show the calculations for
dimers, trimers, tetramers, heptamers, and nine-mers at different ratios of wild-
type and mutant DNAs.
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(8). Indeed, the mature F protein has been found to exist as an
oligomer, although there is some disagreement as to the num-
ber of subunits in the oligomer. It has been argued that the F
protein forms a dimer or tetramer (4, 23). Recently, however,
size determinations on sucrose gradients and cross-linking ex-
periments have suggested that the NDV F protein and the SV5
F protein both form trimers (17, 18).
That the mutant F protein inhibits the activity of the wild-
type protein suggests that inclusion of mutant protein in a
heterooligomer inhibits the activity of the oligomer. This inhi-
bition may take several forms. First, it is possible that the only
active oligomer is composed of entirely wild-type subunits and
that heterooligomers have no activity. In this case, the muta-
tion is strictly a dominant negative mutation. Alternatively, it is
possible that some heterooligomers have partial activity. In this
case, the activity measured in cotransfections with mutant and
wild-type DNAs would be a combination of the activity of fully
wild-type oligomers as well as full or partial activity of some
heterooligomers. In this case, a mutant is not dominant.
The results presented above showed that the expression of F
protein was proportional to the input DNA and that the ex-
pression levels of wild-type and mutant DNAs were compara-
ble for a given amount of DNA. Furthermore, the cleavage
mutants had no effect on cleavage of the wild-type protein, and
heterooligomers likely form. Thus if one assumes that the
formation of oligomers is totally random, i.e., that one to three
amino acid changes in the cleavage site had no effect on oli-
gomer formation, then the concentration of various forms of
homo- and heterooligomers can be calculated for each ratio of
wild-type and mutant DNA according to simple statistical con-
siderations. Calculations can be accomplished with the formula
T 5 wn 1 O
i51
n21
Aiwn21mi 1 mn
where T is the total population of F molecules, w is the fraction
of wild-type molecules, m is the fraction of mutant molecules,
n is the number of subunits in the oligomer, and Ai 5 n!/(i!) z
(n 2 i!). The first term of the equation represents the concen-
tration of fully wild-type oligomers, the last term represents the
concentration of fully mutant oligomers, and the middle term
represents all combinations of heterooligomers. Thus, for a
trimer, the total population is represented by the formula
T 5 w3 1 3w2m 1 3wm2 1 m3
If the concentration of the wild type is 50% of the total, then
the fraction of fully wild-type oligomers would be 12.5%, while
the fraction of trimers containing two wild-type molecules
would be 37.5%, the fraction of oligomers containing only one
wild-type molecule would be 37.5%, and the fraction of mol-
ecules containing only mutant protein would be 12.5%.
The percent of the population at each ratio of wild-type and
mutant DNA composed of only wild-type subunits can be cal-
culated with the first term of the equation. The results for
dimers (n 5 2), trimers (n 5 3), and tetramers (n 5 4), as well
as larger complexes (n 5 6 and n 5 9) are shown in Fig. 8. It
was shown above that the fusion activity was directly propor-
tional to the input DNA; therefore, the activity at different
ratios of wild-type and mutant DNA was compared to that of
these predicted populations. Interestingly, the experimental
values obtained most closely coincided with the predicted con-
centrations of wild-type oligomer if the oligomer were a trimer.
This result indicates that the active form of the F protein is
likely larger than a dimer. The simplest interpretation of these
results is that the active form of F is a trimer and that the active
form contains only wild-type subunits. The data are not con-
sistent with the idea that a trimer with some mutant subunits
has partial activity. If such were the case, the observed activity
at each ratio of DNA would be larger and would fall closer to
the dimer curve or above.
An alternative explanation for the observed results is that
the active form of the F protein is larger than a trimer, such as
a heptamer or a nine-mer. However, if such were the case, then
subunits containing only some wild-type subunits would have
to have partial activity to account for the results obtained. That
is, some of the population represented by the middle term of
the equation would have to have partial activity.
The question of the number of oligomers required for fusion
has been addressed in the influenza virus system by several
approaches, all of which suggest that several trimers must
function together during the fusion process (5, 7, 29). Thus, the
results obtained in this study were unexpected. However, our
results do not preclude the possibility that multiple trimers in
a large complex function in the fusion process mediated by the
paramyxovirus F protein. As noted above, it is possible that
complexes of trimers with some inactive monomers may have
partial activity. However, it should be noted that our attempts
to generate a theoretical curve for a hexomer or a nine-mer
that fit the experimental data assuming various partial activi-
ties of heterooligomers were not successful.
Alternatively, an uncleaved F0 may not interfere with a step
in the fusion process involving multiple oligomers. Studies in a
number of systems have proposed that the fusion process in-
volves multiple steps, including aggregation and activation of
fusion proteins, close approach of target and attack mem-
branes, hemifusion, pore formation, and pore expansion (7,
13). How fusion proteins mediate each of these steps is not well
understood. Perhaps an uncleaved fusion protein is functional
in some steps but not others. If this were the case, the assay
described above may measure the active unit as a trimer and
not a larger complex.
In summary, it was shown that coexpression of two forms of
the NDV F protein, one with a furin site and one without, has
no effect on the cleavage of the F protein with a furin site,
although the cleaved and uncleaved forms of the fusion protein
can form heterooligomers. These results argue that furin rec-
ognizes and cleaves individual subunits of the fusion protein
oligomer. Furthermore, at various ratios of expression of mu-
tant and wild-type protein, results were obtained that are most
consistent with the notion that the size of the functionally
active NDV F protein in syncytium formation is a trimer,
although partial activity of a larger oligomer containing wild-
type and mutant protein cannot be excluded.
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